Concepedia

Leifeng Cheng

LC

7

Publications

276

Citations

7

H-Index

1991

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Thrombosis Research Institute

Leifeng Cheng is an author at AstraZeneca (Sweden) specializing in drug discovery, pharmacotherapy, and medicine.

Top concepts

Publications per year

1991–2014

7

Publications

7

Design, Synthesis, and Proposed Active Site Binding Analysis of Monocyclic 2-Azetidinone Inhibitors of Prostate Specific Antigen

Robert M. Adlington, Jack E. Baldwin, Gerald W. Becker et al. · Journal of Medicinal Chemistry · 2001 · 76 citations · Full text

Substrate-related phosphonopeptides, a new class of thrombin inhibitors

Leifeng Cheng, Christopher A. Goodwin, Michael Scully et al. · Tetrahedron Letters · 1991 · 64 citations

, , +10

Synthesis and biological activity of ketomethylene pseudopeptide analogs as thrombin inhibitors

Leifeng Cheng, Christopher A. Goodwin, Michael F. Schully et al. · Journal of Medicinal Chemistry · 1992 · 45 citations · Full text

, , +23

Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein–Protein Interaction

Leifeng Cheng, Daniel Pettersen, Bengt Ohlsson et al. · ACS Medicinal Chemistry Letters · 2014 · 37 citations · Full text

, , +24

Novel thioamide derivatives as neutral CB1 receptor antagonists

Jonas Boström, Roine I. Olsson, Joakim Tholander et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 27 citations · Full text

, , +4

Rows per page

1–5 of 7